Callan JMB CEO and Management Team Invest $1.5 Million in Common-Only Transaction at a Premium of $1.10 Per Share, Reinforcing Confidence in Growth Strategy

Management supplied personal capital through a common-only transaction, with resale restrictions on the purchased shares.

Rhea-AI Summary

Callan JMB (NASDAQ: CJMB) announced a $1.5 million common-stock investment by CEO Wayne Williams and members of its executive leadership team.

The purchase was described as being at a premium of $1.10 per share. The company expects proceeds to support growth initiatives and other corporate objectives. It has also completed healthcare preparedness initiatives, expanded pharmaceutical supply chain infrastructure, increased advanced manufacturing and launched partnerships with U.S. government-focused programs. The purchased shares carry no registration rights and may be sold or transferred only under SEC Rule 144 holding periods and other conditions.

5 points · 1 major

MixediHow this balance works

How this balance works

Rhea-AI gives every point it takes from this document a weight. Minor counts 1, Moderate 3 and Major 9, so one Major point outweighs several Minor ones. The bar adds up the weights on each side, and when neither side holds more than 65% of the total the balance reads Mixed.

It reads the document as published, with the same rules for every company, and it does not look at what the market expected or at how the stock traded, so a point can be objectively good on a day the stock falls.

Rhea-AI Sentiment measures something else, the tone of the wording.

How the balance worksHow Sentiment works

1 major · 1 point

How the balance works

Positive

• Major point$1.5 million investment by the CEO and executive team provides capital through common-stock purchases. 69% of market cap
• Minor pointHealthcare preparedness initiatives have been completed.
• Minor pointPharmaceutical supply chain infrastructure has expanded.
• Minor pointAdvanced manufacturing has increased.
• Minor pointPartnerships with U.S. government-focused programs have launched.

Negative

• Major pointCommon-stock financing adds equity dilution for existing shareholders.

News Explained

For the announced management common-stock purchase, the release gives neither a share count nor whether the shares were newly issued, so the transaction’s effect on existing holders’ ownership cannot be established.

Key Figures

Management stock investment: $1.5 million Per-share premium: $1.10 per share

Management stock investment

$1.5 million

Personal purchase of common stock by the CEO and executive team

Per-share premium

$1.10 per share

Premium stated for the common-stock purchase

Key Terms

rule 144, registration rights

2 terms

rule 144 regulatory

"in accordance with the holding periods and other conditions prescribed by SEC Rule 144"

Rule 144 is a U.S. securities regulation that sets conditions under which restricted or insider-held shares can be legally resold to the public, such as required holding periods, availability of public information, limits on how much can be sold at once, and certain filing requirements. For investors it matters because it determines when previously locked-up shares can enter the market — like a release valve that can increase supply, affect share price, and signal insider intent.

View in glossary

registration rights financial

"The shares purchased do not benefit from any registration rights"

Registration rights are contractual promises that let investors require a company to file paperwork with securities regulators so those investors can sell their shares to the public. They matter because they create a path to liquidity and an exit plan—without them, investors may be stuck holding shares for a long time. Think of them like a reserved ticket that guarantees access to a public marketplace when the holder is ready to sell.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

SPRING BRANCH, Texas, Nov. 12, 2026 (GLOBE NEWSWIRE) -- Callan JMB Inc. (NASDAQ: CJMB) (“Callan JMB” or the “Company”), a provider of logistics, emergency preparedness, and critical supply chain solutions for the healthcare industry and government organizations, today announced that CEO Wayne Williams and members of its executive leadership team have invested $1.5 million personally through the purchase of common stock at a premium of $1.10 per share.

The investment underscores management’s conviction in Callan JMB’s strategic direction, operational progress, and short- and long-term growth opportunities.

“Our leadership team is putting its own capital to work because we believe in the path ahead,” said Wayne Williams, Chief Executive Officer of Callan JMB. “This is a direct expression of our confidence in the Company’s strategy, and our commitment to building value alongside shareholders.”

The investment arrives as Callan JMB has recently completed multiple important initiatives across healthcare preparedness, expanded pharmaceutical supply chain infrastructure, increased advanced manufacturing, and launched strategic partnerships with U.S. government-focused programs, achieving the goal of strengthening domestic healthcare resiliency and critical medical supply chains. Management believes the Company’s rapidly growing pipeline of business opportunities positions it to capitalize on rising demand while executing its plan for growth and operational excellence.

“We believe the strongest signal we can send is to invest our own capital at a price that is at a multiple above the current market, but still at what we perceive to be a discount to the true value of our shares. Investing alongside our shareholders demonstrates our confidence in the company,” said Christopher Shields, Interim Chief Financial Officer. “We remain focused on disciplined execution and creating sustainable value for all stakeholders.”

Proceeds from the investment are expected to support strategic growth initiatives and other corporate objectives that significantly strengthen the Company’s market position.

Shareholder Alignment

By committing personal capital at this level, Callan JMB’s executive leadership is further aligning its interests with those of shareholders. The investment reinforces management’s total confidence in the Company’s strategic initiatives and its commitment to responsible stewardship of shareholder capital.

The shares purchased do not benefit from any registration rights and may only be sold or transferred in accordance with the holding periods and other conditions prescribed by SEC Rule 144.

About Callan JMB Inc.

Callan JMB Inc. (NASDAQ: CJMB) provides logistics, infrastructure, and operational services supporting the healthcare industry, emergency management agencies, government organizations, and other entities responsible for maintaining essential services. The Company’s capabilities include product fulfillment, specialty packaging, warehousing, cold-chain logistics, monitoring, regulatory compliance, emergency preparedness, and response operations. Through continued expansion, Callan JMB is leveraging its expertise in critical infrastructure and supply chain management to address challenges of national importance.

Investor Contact
Valter Pinto
Managing Director
KCSA Strategic Communications
CallanJMB@kcsa.com
(212) 896-1254

Media Contact
Arian Hopkins
ahopkins@callanjmb.com

Forward-Looking Statements

This press release contains “forward-looking statements” within the meaning of applicable federal securities laws. Such statements include, but are not limited to, statements regarding the Company’s growth strategy, business opportunities, operational expansion, healthcare preparedness initiatives, manufacturing capabilities, supply chain objectives, expected market demand, strategic partnerships, workforce development initiatives, and other statements that are not historical facts. These forward-looking statements are based on current expectations and assumptions and are subject to risks, uncertainties, and other factors that could cause actual results to differ materially from those expressed or implied. Investors are encouraged to review the Company’s filings with the U.S. Securities and Exchange Commission for a discussion of factors that could affect future results. The Company undertakes no obligation to update any forward-looking statements except as required by law.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

How much did Callan JMB management invest in CJMB common stock?

CEO Wayne Williams and members of Callan JMB’s executive leadership team personally invested $1.5 million through common-stock purchases. The transaction was described as being at a premium of $1.10 per share.

Can Callan JMB executives immediately resell the shares purchased in the management investment?

The purchased shares may only be sold or transferred in accordance with SEC Rule 144 holding periods and other conditions. They do not carry registration rights.